BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 11, 2025
See today's BioWorld
Home
» GWAS Comes to Side Effects; XL184 Comes to Metastases
To read the full story,
subscribe
or
sign in
.
GWAS Comes to Side Effects; XL184 Comes to Metastases
May 19, 2011
By
Anette Breindl
No Comments
It was a late night for analysts yesterday, as the American Society of Clinical Oncology (ASCO) released more than 4,000 abstracts in advance of its upcoming annual meeting at 6 pm.
BioWorld
